Cite
In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria
MLA
Parvin Askari, et al. “In Vitro and in Vivo Toxicity and Antibacterial Efficacy of Melittin against Clinical Extensively Drug-Resistant Bacteria.” BMC Pharmacology and Toxicology, vol. 22, no. 1, July 2021, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s40360-021-00503-z.
APA
Parvin Askari, Mohammad Hasan Namaei, Kiarash Ghazvini, & Mehran Hosseini. (2021). In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria. BMC Pharmacology and Toxicology, 22(1), 1–12. https://doi.org/10.1186/s40360-021-00503-z
Chicago
Parvin Askari, Mohammad Hasan Namaei, Kiarash Ghazvini, and Mehran Hosseini. 2021. “In Vitro and in Vivo Toxicity and Antibacterial Efficacy of Melittin against Clinical Extensively Drug-Resistant Bacteria.” BMC Pharmacology and Toxicology 22 (1): 1–12. doi:10.1186/s40360-021-00503-z.